Associated Papers
Structural insights into the complex of oncogenic KRas4BG12V and Rgl2, a RalA/B activator.
Tariq M et al.
Life Science Alliance, 2024
Beyond structural bioinformatics for genomics with dynamics characterization of an expanded KRAS mutational landscape.
Ratnasinghe BD et al.
Computational and Structural Biotechnology Journal, 2023
Delineating the RAS Conformational Landscape.
Parker MI et al.
Cancer Research, 2022
35536216 (PubMed )
Supplement: can-22-0804_supplementary_datasets_s1-s4_suppsds1-sds4.xlsx › Supplementary_Dataset_S1
Structures of RGL1 RAS-Association Domain in Complex with KRAS and the Oncogenic G12V Mutant.
Eves BJ et al.
Journal of Molecular Biology, 2022
Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II.
Stieglitz B et al.
The Embo Journal, 2008
Differential structural requirements for interaction of Ras protein with its distinct downstream effectors.
Akasaka K et al.
The Journal of Biological Chemistry, 1996
c-Ha-Ras mutants with point mutations in Gln-Val-Val region have reduced inhibitory activity toward cathepsin B.
Hiwasa T et al.
Cancer Letters, 1993
A comprehensive analysis of RAS-effector interactions reveals interaction hotspots and new binding partners.
Rezaei Adariani S et al.
The Journal of Biological Chemistry, 0
33930461 (PubMed )
Supplement: mmc1.pdf
Select a paper to view details